Robert J. More's most recent trade in Tyra Biosciences Inc was a trade of 13,160 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2026 | 13,160 | 13,160 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 8,000 | 48,656 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 19 Dec 2025 | 10,000 | 3,823,425 | - | 25 | 250,000 | Common Stock |
| Tyra Biosciences Inc | Robert J. More | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 21 Nov 2025 | 246,871 | 3,833,425 | - | 20.3 | 5,000,026 | Common Stock |
| Vir biotech Inc | Robert J. More | Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2025 | 14,027 | 509,917 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Robert J. More | Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2025 | 14,027 | 40,656 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 8,000 | 54,683 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 46,683 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 18,600 | 18,600 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 12,054 | 12,054 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 6,027 | 45,088 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 14,500 | 14,500 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 3,374 | 489,485 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Robert J. More | Director | Other type of transaction at price $ 0.00 per share. | 09 Jun 2022 | 3,374 | 39,061 (0%) | 0% | 0 | Common Stock | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 12,810 | 12,810 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Robert J. More | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,405 | 42,435 (0%) | 0% | 0 | Common Stock | |
| Tyra Biosciences Inc | Robert J. More | Director | 17 Sep 2021 | 3,811,117 | 3,924,046 | - | - | Common Stock | ||
| Tyra Biosciences Inc | Robert J. More | Director | 17 Sep 2021 | 1,212,122 | 0 | - | - | Series A Preferred Stock | ||
| Tyra Biosciences Inc | Robert J. More | Director | 17 Sep 2021 | 255,160 | 0 | - | - | Series B Preferred Stock | ||
| Tyra Biosciences Inc | Robert J. More | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 17 Sep 2021 | 156,250 | 4,080,296 | - | 16 | 2,500,000 | Common Stock |